Literature DB >> 20186746

Complement fragments C3a and C5a: the salt and pepper of the immune response.

Steven H Sacks1.   

Abstract

The influence of complement on B-cell responses has been known for many years, but the notion that T-cell recognition, expansion and differentiation are complement dependent has only recently gained impetus. DC, and to a lesser extent T cells, produce a range of complement components necessary for complement activation, and these cells also express receptors that detect complement-activation products such as C3a and C5a (anaphylatoxins). In the absence of C3a-receptor (C3aR) signalling, DC lose their capacity to induce potent Th1 responses against alloantigen and also favour the emergence of Treg. A study in this issue of the European Journal of Immunology not only spotlights the importance of C5aR signalling in DC interaction with T cells, but also shows how cooperation with other signalling pathways determines the outcome of T-cell activation. Remove C5aR from the equation, TLR2-stimulated DC induce naive CD4(+) Th cells to undergo differentiation not only mainly to Th17 cells but also to Treg, via a TGF-beta-dependent pathway. Thus, anaphylatoxins in conjunction with other danger signalling pathways modify the function of DC in antigen presentation and help to shape the primary immune response. Future work will need to address the impact of anaphylatoxins on protective immunity in vivo and determine the wider implications of anaphylatoxins for allo- and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186746     DOI: 10.1002/eji.201040355

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

1.  Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

Authors:  Qing Ma; Dan Li; Roza Nurieva; Rebecca Patenia; Roland Bassett; Wei Cao; Andrei M Alekseev; Hong He; Jeffrey J Molldrem; Michael H Kroll; Richard E Champlin; George E Sale; Vahid Afshar-Kharghan
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-01       Impact factor: 5.742

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Which anti-platelet therapies might be beneficial in xenotransplantation?

Authors:  Moritz Schmelzle; Peter J Cowan; Simon C Robson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

4.  Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.

Authors:  Hongmei Gu; Elizabeth A Mickler; Oscar W Cummings; George E Sandusky; Daniel J Weber; Adam Gracon; Trent Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2014-06-23       Impact factor: 5.191

Review 5.  Molecular basis for downregulation of C5a-mediated inflammation by IgG1 immune complexes in allergy and asthma.

Authors:  Manoj Kumar Pandey
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Authors:  Xiaomei Chen; Peilong Lai; Yulian Wang; Chang He; Suijing Wu; Xin Huang; Suxia Geng; Chengwei Luo; Wei Ling; Lingji Zeng; Peng Li; Zhiwu Jiang; Jianyu Weng; Xin Du
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 8.  The complex functioning of the complement system in xenotransplantation.

Authors:  Hongmin Zhou; Hidetaka Hara; David K C Cooper
Journal:  Xenotransplantation       Date:  2019-04-29       Impact factor: 3.907

Review 9.  The role of the complement system in cancer.

Authors:  Vahid Afshar-Kharghan
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

10.  Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.

Authors:  Jeff W Kwak; Jennifer Laskowski; Howard Y Li; Maria V McSharry; Trisha R Sippel; Bonnie L Bullock; Amber M Johnson; Joanna M Poczobutt; Alexander J Neuwelt; Stephen P Malkoski; Mary C Weiser-Evans; John D Lambris; Eric T Clambey; Joshua M Thurman; Raphael A Nemenoff
Journal:  Cancer Res       Date:  2017-11-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.